← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 3, 2017Last known activity
Feb 7, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 5 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT07150065Lead sponsorPhase 2Feb 7, 2025
- NCT07150065Sponsor investigatorPhase 2Feb 7, 2025
- NCT07078708Sponsor investigatorN/AJun 1, 2024
- NCT07078708Lead sponsorN/AJun 1, 2024
- NCT05019287Lead sponsorPhase 1/Phase 2Apr 17, 2021
- NCT05703308Lead sponsorPhase 3Jun 21, 2020
- NCT03416062Overall official - principal investigatorPhase 3Apr 3, 2017
Details
- Last known activity
- Feb 7, 2025